Transcriptomic analysis shows that surgical treatment is likely to influence the endometrial receptivity of patients with stage III/IV endometriosis

被引:3
|
作者
Xiang, Rui [1 ]
Chen, Peigen [1 ]
Zeng, Zhi [1 ]
Liu, Huijun [1 ]
Zhou, Juan [2 ]
Zhou, Chuanchuan [1 ]
Peng, Jintao [1 ]
Zeng, Haitao [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 6, Reprod Med Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Gynecol & Obstet, Guangzhou, Peoples R China
来源
关键词
endometriosis (EM); surgical treatment; endometrial receptivity; RNA sequencing (RNA-seq); secretory endometrium (SE); immune cell profile; EUTOPIC ENDOMETRIUM; EXPRESSION; WOMEN; CELLS; IMPLANTATION; GENE; CYTOSCAPE; PATHWAY; ALPHA; PROLIFERATION;
D O I
10.3389/fendo.2022.932339
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundEndometriosis negatively affects fertility, and it is a common disease in assisted reproductive practice. Surgical removal of endometriotic lesions is widely carried out to relieve symptoms and promote fertility. But it is not intensively investigated what changes in the secretory eutopic endometrium of patients with endometriosis after surgery. MethodsEighteen patients with stage III/IV endometriosis were included in the study, and they were divided into the untreated group and the treated group (6 vs. 12). Basic clinical data were compared, and transcriptomic data of the secretory eutopic endometrium were analyzed with DESeq2, Cytoscape, ClueGO, CluePedia, and Gene Set Enrichment Analysis (GSEA). CIBERSORT was used to calculate the relative abundance of 22 immune cells in the samples. ResultsWe determined 346 differentially expressed genes (DEGs) using DESeq2. These DEGs were used to enrich seven Gene Ontology terms including three associated with immune processes and one correlated to prostaglandin using ClueGO and CluePedia. GSEA enriched 28 Gene Ontology terms in the treated group mainly associated with immune and blood pressure regulation process. Compared to the untreated group, the relative abundance of resting CD4+ memory T cells [0.218 (0.069, 0.334) vs. 0.332 (0.181, 0.429), P = 0.022] and the even less abundant memory B cells [0.001 (0.000, 0.083) vs. 0.033 (0.007, 0.057), P = 0.049] are significantly decreased in the treated group. ConclusionSurgical treatment of stage III/IV endometriosis influences some genes and biological processes related to endometrial receptivity, but more evidence is needed.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelia ovarian cancer
    Everett, Elise N.
    French, Amy E.
    Stone, Rebecca L.
    Pastore, Lisa M.
    Jazaeri, Amir A.
    Andersen, Willie A.
    Taylor, Peyton T., Jr.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (02) : 568 - 574
  • [32] Efficacy of multimodality treatment in survival patterns among patients with endometrial carcinoma stage III
    Elemam, R. E.
    Uthman, I.
    Yahya, A.
    Mohamed, N.
    Shaltout, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [33] The influence of roflumilast on the IV-type collagen level in patients with III stage COPD
    Ostrovskyy, Mykola
    Varunkiv, Oleksandr
    Savelikhina, Iryna
    Kulynych-Miskiv, Mariana
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [34] A RETROSPECTIVE ANALYSIS OF 53 PATIENTS WITH PATHOLOGIC STAGE-II AND STAGE-III ENDOMETRIAL CARCINOMA
    DEPALO, G
    KENDA, R
    ANDREOLA, S
    BANDIERAMONTE, G
    LUCIANI, L
    STEFANON, B
    TUMORI, 1982, 68 (04) : 341 - 347
  • [35] Cost minimization analysis of various treatment options for surgical stage I endometrial carcinoma
    Konski, AA
    Bracy, PM
    Jurs, SG
    Weiss, SJ
    Zeidner, SR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (02): : 367 - 373
  • [36] High-risk surgical stage 1 endometrial cancer: Analysis of treatment outcome
    Viani G.A.
    Patia B.F.
    Pellizzon A.C.
    De Melo M.D.
    Novaes P.E.
    Fogaroli R.C.
    Conte M.A.
    Salvajoli J.V.
    Radiation Oncology, 1 (1)
  • [37] Treatment of patients with inoperable stage III or stage IV melanoma. Societe francaise de dermatologie
    Guillot, B.
    Charles, J.
    Jeudy, G.
    Cupissol, D.
    Dupuy, A.
    Dutriaux, C.
    Gangloff, D.
    Magne, N.
    Mirabe, X.
    M'Sadek, A.
    Pracht, M.
    Sichel, C.
    Do Outeiro, G.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (6-7): : 413 - 422
  • [38] Ovarian suppression treatment prior to in-vitro fertilization and embryo transfer in Chinese women with stage III or IV endometriosis
    Ma, Caihong
    Qiao, Jie
    Liu, Ping
    Chen, Guian
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 100 (02) : 167 - 170
  • [39] Surgical treatment experience for patients with stage I-III esophageal cancer
    Kolesnik, O. P.
    Kolesnyk, I. P.
    Kechedzhyiev, V. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2018, (03) : 448 - 453